Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions-Reference-Cited by-同舟云学术

Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions

Published:2016-09-22 Issue:3 Volume:58 Page:445-450
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Okamoto Shozo,Thieme Anne,Allmann Jakob,D’Alessandria Calogero,Maurer Tobias,Retz Margitta,Tauber Robert,Heck Matthias M.,Wester Hans-Juergen,Tamaki Nagara,Fendler Wolfgang P.,Herrmann Ken,Pfob Christian H.,Scheidhauer Klemens,Schwaiger Markus,Ziegler Sibylle,Eiber Matthias

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference31 articles.

1. International Variation in Prostate Cancer Incidence and Mortality Rates

2. Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy

3. Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy

4. Prostate-specific membrane antigen expression as a predictor of prostate cancer progression

5. PSMA ligands for radionuclide imaging and therapy of prostate cancer: clinical status;Lütje;Theranostics.,2015

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient organ dose during multicycle radiation dosimetry in Lutetium −177 radionuclide therapy;Radiation Physics and Chemistry;2024-11

2. Efficacy and safety of rechallenge with [177Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-03

3. Pharmacokinetic Comparison of Selective Prostatic Arterial and Intravenous PSMA PET/CT Radioligand Infusions in Primary Prostatic Adenocarcinoma;Radiology;2024-08-01

4. A review of 177Lu dosimetry workflows: how to reduce the imaging workloads?;EJNMMI Physics;2024-07-18

5. Organ and tumor dosimetry including method simplification for [177Lu]Lu-PSMA-I&T for treatment of metastatic castration resistant prostate cancer;EJNMMI Physics;2024-07-17